Sequential Administration of GM-CSF (Sargramostim®) and IL-2 ± Autologous Vaccine as Adjuvant Therapy in Cutaneous Melanoma: An Interim Report of a Phase II Clinical Trial

Title
Sequential Administration of GM-CSF (Sargramostim®) and IL-2 ± Autologous Vaccine as Adjuvant Therapy in Cutaneous Melanoma: An Interim Report of a Phase II Clinical Trial
Authors
Keywords
-
Journal
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
Volume 23, Issue 3, Pages 285-291
Publisher
Mary Ann Liebert Inc
Online
2008-07-02
DOI
10.1089/cbr.2007.0438

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search